{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:01:33Z","timestamp":1785528093152,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Furong Scholars Program of Hunan Province and the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South Universit","award":["No.BJ202504"],"award-info":[{"award-number":["No.BJ202504"]}]},{"name":"The Hunan Provincial Natural Science Foundation","award":["No. 2024JJ8123"],"award-info":[{"award-number":["No. 2024JJ8123"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82472029"],"award-info":[{"award-number":["No.82472029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Graduate Innovation Project of Central South University","award":["NO.2024XQLH112"],"award-info":[{"award-number":["NO.2024XQLH112"]}]},{"name":"The Furong Scholars Program of Hunan Province and the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University","award":["BJ202505"],"award-info":[{"award-number":["BJ202505"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00259-026-07961-9","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:01:06Z","timestamp":1780041666000},"page":"5844-5852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of PET imaging of [18F]F-FAPI and [18F]F-FDG for diagnosis of suspected lymph node metastases in penile squamous cell carcinoma: a prospective pilot study"],"prefix":"10.1007","volume":"53","author":[{"given":"Wei","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-2428","authenticated-orcid":false,"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"1","key":"7961_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"7961_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","volume":"5","author":"S Misra","year":"2004","unstructured":"Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol. 2004;5(4):240\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(04)01427-5.","journal-title":"Lancet Oncol"},{"issue":"2 Suppl 1","key":"7961_CR3","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","volume":"76","author":"V Ficarra","year":"2010","unstructured":"Ficarra V, Akduman B, Bouchot O, et al. Prognostic factors in penile cancer. Urology. 2010;76(2 Suppl 1):S66-73. https:\/\/doi.org\/10.1016\/j.urology.2010.04.008.","journal-title":"Urology"},{"issue":"5","key":"7961_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21037\/tau.2017.05.19","volume":"6","author":"A Douglawi","year":"2017","unstructured":"Douglawi A, Masterson TA. Updates on the epidemiology and risk factors for penile cancer. Transl Androl Urol. 2017;6(5):785\u201390. https:\/\/doi.org\/10.21037\/tau.2017.05.19.","journal-title":"Transl Androl Urol"},{"issue":"6","key":"7961_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","volume":"83","author":"OR Brouwer","year":"2023","unstructured":"Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update. Eur Urol. 2023;83(6):548\u201360. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.027.","journal-title":"Eur Urol"},{"key":"7961_CR6","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978\u201394\u201392671\u201323\u20133."},{"key":"7961_CR7","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Penile Cancer. Version 2.2025 \u2014 2025."},{"issue":"5","key":"7961_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","volume":"37","author":"R Sadeghi","year":"2012","unstructured":"Sadeghi R, Gholami H, Zakavi SR, et al. Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med. 2012;37(5):436\u201341. https:\/\/doi.org\/10.1097\/RLU.0b013e318238f6ea.","journal-title":"Clin Nucl Med"},{"issue":"12","key":"7961_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.2967\/jnumed.123.265751","volume":"64","author":"TT Demmert","year":"2023","unstructured":"Demmert TT, Pomykala KL, Lanzafame H, et al. Oncologic staging with (68)Ga-FAPI PET\/CT demonstrates a lower rate of nonspecific lymph node findings than (18)F-FDG PET\/CT. J Nucl Med. 2023;64(12):1906\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.265751.","journal-title":"J Nucl Med"},{"issue":"2","key":"7961_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.juro.2010.03.145","volume":"184","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, Zhang HL, Yao XD, et al. Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol. 2010;184(2):539\u201345. https:\/\/doi.org\/10.1016\/j.juro.2010.03.145.","journal-title":"J Urol"},{"issue":"2","key":"7961_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","volume":"298","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, et al. Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. 2021;298(2):393\u2013402. https:\/\/doi.org\/10.1148\/radiol.2020203275.","journal-title":"Radiology"},{"issue":"4","key":"7961_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7150\/thno.69475","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Chen J, Pang Y, et al. Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review. Theranostics. 2022;12(4):1557\u201369. https:\/\/doi.org\/10.7150\/thno.69475.","journal-title":"Theranostics"},{"issue":"8","key":"7961_CR13","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7961_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005973","author":"YS Kim","year":"2025","unstructured":"Kim YS, Kim SJ. Diagnostic performances of radiolabeled FAPI PET\/CT for lymph node staging in head and neck cancer patients: comparison with 18F-FDG PET\/CT. Clin Nucl Med. 2025. https:\/\/doi.org\/10.1097\/RLU.0000000000005973.","journal-title":"Clin Nucl Med"},{"key":"7961_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07277-0","author":"A Florit","year":"2025","unstructured":"Florit A, de Koster EJ, Sassano S, et al. Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [(18)F]FDG in gynaecological malignancies: systematic literature review and meta-analysis. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07277-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"7961_CR16","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s00259-024-06763-1","volume":"51","author":"L Eismann","year":"2024","unstructured":"Eismann L, Ledderose ST, Enzinger B, et al. [(68)Ga]Ga-FAPI-46 PET\/CT for penile cancer - a feasibility study. Eur J Nucl Med Mol Imaging. 2024;51(11):3461\u20134. https:\/\/doi.org\/10.1007\/s00259-024-06763-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"7961_CR17","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","volume":"48","author":"S Wang","year":"2021","unstructured":"Wang S, Zhou X, Xu X, et al. Clinical translational evaluation of Al(18)F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging. Eur J Nucl Med Mol Imaging. 2021;48(13):4259\u201371. https:\/\/doi.org\/10.1007\/s00259-021-05470-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7961_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07523-5","author":"M Zhao","year":"2025","unstructured":"Zhao M, Zhou C, Fang H, et al. [18F]F-FAPI PET\/CT outperforms [18F]F-FDG PET\/CT in predicting treatment response in lupus nephritis. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07523-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"7961_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"7961_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bju.15206","volume":"127","author":"JK Jakobsen","year":"2021","unstructured":"Jakobsen JK, Frahm Nielsen T, Ipsen P, et al. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography\/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer. BJU Int. 2021;127(2):254\u201362. https:\/\/doi.org\/10.1111\/bju.15206.","journal-title":"BJU Int"},{"issue":"7","key":"7961_CR21","doi-asserted-by":"publisher","first-page":"103481","DOI":"10.1016\/j.esmoop.2024.103481","volume":"9","author":"A Muneer","year":"2024","unstructured":"Muneer A, Bandini M, Comperat E, et al. Penile cancer: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024;9(7):103481. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103481.","journal-title":"ESMO Open"},{"issue":"4","key":"7961_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2967\/jnumed.122.264638","volume":"64","author":"X Hu","year":"2023","unstructured":"Hu X, Zhou T, Ren J, et al. Response prediction using (18)F-FAPI-04 PET\/CT in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. J Nucl Med. 2023;64(4):625\u201331. https:\/\/doi.org\/10.2967\/jnumed.122.264638.","journal-title":"J Nucl Med"},{"issue":"13","key":"7961_CR23","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","volume":"48","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J, et al. Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging. 2021;48(13):4377\u201385. https:\/\/doi.org\/10.1007\/s00259-021-05307-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"7961_CR24","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","volume":"48","author":"K Dendl","year":"2021","unstructured":"Dendl K, Koerber SA, Finck R, et al. (68)Ga-FAPI-PET\/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021;48(12):4089\u2013100. https:\/\/doi.org\/10.1007\/s00259-021-05378-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7961_CR25","doi-asserted-by":"publisher","first-page":"e194003","DOI":"10.1148\/rycan.2019194003","volume":"1","author":"DK Hathi","year":"2019","unstructured":"Hathi DK, Jones EF. (68)Ga FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. Radiol Imaging Cancer. 2019;1(1):e194003. https:\/\/doi.org\/10.1148\/rycan.2019194003.","journal-title":"Radiol Imaging Cancer"},{"issue":"9","key":"7961_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/RLU.0000000000005973","volume":"50","author":"YS Kim","year":"2025","unstructured":"Kim YS, Kim SJ. Diagnostic performances of radiolabeled FAPI PET\/CT for lymph node staging in head and neck cancer patients: comparison with 18 F-FDG PET\/CT. Clin Nucl Med. 2025;50(9):840\u20136. https:\/\/doi.org\/10.1097\/RLU.0000000000005973.","journal-title":"Clin Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07961-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:17:51Z","timestamp":1785521871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07961-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7961"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07961-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Third Xiangya Hospital (NO.24429).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a0\n                      \n                      ,\n                      \n                      and S1, S2.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}